Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.

Frenck RW Jr, Ervin J, Chu L, Abbanat D, Spiessens B, Go O, Haazen W, van den Dobbelsteen G, Poolman J, Thoelen S, Ibarra de Palacios P.

Lancet Infect Dis. 2019 Jun;19(6):631-640. doi: 10.1016/S1473-3099(18)30803-X. Epub 2019 May 9.

PMID:
31079947
2.

A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.

Frenck RW Jr, Baqar S, Alexander W, Dickey M, McNeal M, El-Khorazaty J, Baughman H, Hoeper A, Barnoy S, Suvarnapunya AE, Kaminski RW, Venkatesan MM.

Vaccine. 2018 Aug 6;36(32 Pt B):4880-4889. doi: 10.1016/j.vaccine.2018.06.063. Epub 2018 Jul 2.

PMID:
30037478
3.

Cat-Scratch Disease, a Diagnostic Consideration for Chronic Recurrent Multifocal Osteomyelitis.

Harry O, Schulert GS, Frenck RW Jr, Shapiro AH, Woltmann JL, Smith JA, Grom AA.

J Clin Rheumatol. 2018 Aug;24(5):287-290. doi: 10.1097/RHU.0000000000000653. No abstract available.

PMID:
29239936
4.

Developing and utilizing controlled human models of infection.

Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS.

Vaccine. 2017 Dec 14;35(49 Pt A):6813-6818. doi: 10.1016/j.vaccine.2017.05.068. Epub 2017 Jun 3.

5.

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.

Klein NP, Abu-Elyazeed R, Cornish M, Leonardi ML, Weiner LB, Silas PE, Grogg SE, Varman M, Frenck RW, Cheuvart B, Baine Y, Miller JM, Leyssen M, Mesaros N, Roy-Ghanta S.

Vaccine. 2017 Jun 16;35(28):3564-3574. doi: 10.1016/j.vaccine.2017.05.018. Epub 2017 May 20.

6.

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Frenck RW Jr, Creech CB, Sheldon EA, Seiden DJ, Kankam MK, Baber J, Zito E, Hubler R, Eiden J, Severs JM, Sebastian S, Nanra J, Jansen KU, Gruber WC, Anderson AS, Girgenti D.

Vaccine. 2017 Jan 5;35(2):375-384. doi: 10.1016/j.vaccine.2016.11.010. Epub 2016 Dec 1.

7.

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Creech CB, Frenck RW Jr, Sheldon EA, Seiden DJ, Kankam MK, Zito ET, Girgenti D, Severs JM, Immermann FW, McNeil LK, Cooper D, Jansen KU, Gruber W, Eiden J, Anderson AS, Baber J.

Vaccine. 2017 Jan 5;35(2):385-394. doi: 10.1016/j.vaccine.2016.11.032. Epub 2016 Nov 17.

8.
9.

Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.

Frenck RW Jr, Fiquet A, Gurtman A, van Cleeff M, Davis M, Rubino J, Smith W, Sundaraiyer V, Sidhu M, Emini EA, Gruber WC, Scott DA, Schmoele-Thoma B; B1851020 Study Group.

Vaccine. 2016 Jun 24;34(30):3454-62. doi: 10.1016/j.vaccine.2016.04.093. Epub 2016 May 5.

PMID:
27155493
10.

Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia.

Hahn A, Fukuda T, Hahn D, Mizuno T, Frenck RW Jr, Vinks AA.

Pharmacogenomics. 2016 Apr;17(6):547-59. doi: 10.2217/pgs-2015-0008. Epub 2016 Apr 5.

11.

A cross-sectional household cluster serosurvey of hepatitis C virus antibodies in an urban slum of Cairo, Egypt in 2004.

Nakhla IA, Sanders JW, Mohareb EW, Samy S, Cosby MT, Mostafa MM, Riddle MS, Frenck RW Jr.

Trop Dis Travel Med Vaccines. 2015 Oct 1;1:9. doi: 10.1186/s40794-015-0012-7. eCollection 2015.

12.

Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.

Hahn A, Frenck RW Jr, Allen-Staat M, Zou Y, Vinks AA.

Ther Drug Monit. 2015 Oct;37(5):619-25. doi: 10.1097/FTD.0000000000000190.

13.

Serological Correlates of Protection against a GII.4 Norovirus.

Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM.

Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3.

14.

Validation of a pediatric population pharmacokinetic model for vancomycin.

Hahn A, Frenck RW Jr, Zou Y, Vinks AA.

Ther Drug Monit. 2015 Jun;37(3):413-6. doi: 10.1097/FTD.0000000000000153.

15.

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM.

J Infect Dis. 2015 Mar 15;211(6):870-8. doi: 10.1093/infdis/jiu497. Epub 2014 Sep 9.

16.

The epidemiological and clinical characteristics of diarrhea associated with enteropathogenic, enteroaggregative and diffuse-adherent Escherichia coli in Egyptian children.

Ahmed SF, Shaheen HI, Abdel-Messih IA, Mostafa M, Putnam SD, Kamal KA, Sayed AN, Frenck RW Jr, Sanders JW, Klena JD, Wierzba TF.

J Trop Pediatr. 2014 Oct;60(5):397-400. doi: 10.1093/tropej/fmu034. Epub 2014 Aug 13.

PMID:
25122630
17.

Diarrhea burden due to natural infection with enterotoxigenic Escherichia coli in a birth cohort in a rural Egyptian community.

Mansour A, Shaheen HI, Amine M, Hassan K, Sanders JW, Riddle MS, Armstrong AW, Svennerholm AM, Sebeny PJ, Klena JD, Young SY, Frenck RW.

J Clin Microbiol. 2014 Jul;52(7):2595-603. doi: 10.1128/JCM.00215-14. Epub 2014 May 14.

18.

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Vaccine. 2014 Apr 25;32(20):2364-74. doi: 10.1016/j.vaccine.2014.02.002. Epub 2014 Mar 5.

PMID:
24606865
19.

Pathogenicity and phenotypic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural Egypt.

Mansour A, Shaheen HI, Amine M, Hassan K, Sanders JW, Riddle MS, Armstrong AW, Svennerholm AM, Sebeny PJ, Klena JD, Young SY, Frenck RW Jr.

J Clin Microbiol. 2014 Feb;52(2):587-91. doi: 10.1128/JCM.01639-13. Epub 2013 Dec 11.

20.

Polyarthritis in a 19-year-old female with systemic lupus erythematosus.

Hahn A, Ting TV, Taylor J, Frenck RW Jr.

Clin Pediatr (Phila). 2013 Oct;52(10):991-3. doi: 10.1177/0009922813498155. Epub 2013 Aug 5. No abstract available.

21.

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.

Jackson LA, Gurtman A, van Cleeff M, Frenck RW, Treanor J, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Vaccine. 2013 Aug 2;31(35):3594-602. doi: 10.1016/j.vaccine.2013.04.084. Epub 2013 May 18.

22.

Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United States.

Payton T, Girgenti D, Frenck RW, Patterson S, Love J, Razmpour A, Sidhu MS, Emini EA, Gruber WC, Scott DA.

Pediatr Infect Dis J. 2013 Aug;32(8):871-80. doi: 10.1097/INF.0b013e3182906499.

PMID:
23584582
23.

Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.

Frenck RW Jr, Gurtman A, Rubino J, Smith W, van Cleeff M, Jayawardene D, Giardina PC, Emini EA, Gruber WC, Scott DA, Schmöle-Thoma B.

Clin Vaccine Immunol. 2012 Aug;19(8):1296-303. doi: 10.1128/CVI.00176-12. Epub 2012 Jun 27.

24.

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults.

Frenck RW Jr, Yeh S.

Expert Opin Biol Ther. 2012 Jan;12(1):63-77. doi: 10.1517/14712598.2012.636348. Epub 2011 Nov 10. Review.

PMID:
22074323
25.

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.

Frenck RW Jr, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB Jr, Cate TR, Edwards KM, Hill H, Wolff M, Leduc T, Tornieporth N.

Vaccine. 2011 Aug 5;29(34):5666-74. doi: 10.1016/j.vaccine.2011.06.010. Epub 2011 Jun 23.

26.

A prospective study of acute diarrhea in a cohort of United States military personnel on deployment to the Multinational Force and Observers, Sinai, Egypt.

Riddle MS, Rockabrand DM, Schlett C, Monteville MR, Frenck RW, Romine M, Ahmed SF, Sanders JW.

Am J Trop Med Hyg. 2011 Jan;84(1):59-64. doi: 10.4269/ajtmh.2011.10-0093.

27.

Adolescent pneumonia.

Schlaudecker EP, Frenck RW Jr.

Adolesc Med State Art Rev. 2010 Aug;21(2):202-19, vii-viii. Review.

PMID:
21047025
28.

Infectious diseases and immunizations. Preface.

Braverman PK, Frenck RW Jr, Holland-Hall C.

Adolesc Med State Art Rev. 2010 Aug;21(2):xii. No abstract available.

PMID:
21047022
29.

Rotavirus genotypes among hospitalized children in Egypt, 2000-2002.

Matson DO, Abdel-Messih IA, Schlett CD, Bok K, Wienkopff T, Wierzba TF, Sanders JW, Frenck RW Jr.

J Infect Dis. 2010 Sep 1;202 Suppl:S263-5. doi: 10.1086/653581.

PMID:
20684714
30.

Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.

Frenck RW Jr, Seward JF.

Arthritis Care Res (Hoboken). 2010 Jul;62(7):903-6. doi: 10.1002/acr.20234. No abstract available.

31.

Brucella meningitis: first reported case in Egypt.

Mansour AM, Nakhla II, Sultan YA, Frenck RW Jr.

East Mediterr Health J. 2009 Jul-Aug;15(4):1040-4. No abstract available.

32.

The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli.

Porter CK, Riddle MS, Tribble DR, Putnam SD, Rockabrand DM, Frenck RW, Rozmajzl P, Kilbane E, Fox A, Ruck R, Lim M, Johnston J, Murphy E, Sanders JW.

Diagn Microbiol Infect Dis. 2010 Mar;66(3):241-7. doi: 10.1016/j.diagmicrobio.2009.10.002. Epub 2009 Nov 10.

PMID:
19903582
33.

Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.

Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, Simpson P, Barolet-Garcia C, Ward J, Targan SR, Vasiliauskas EA.

Am J Gastroenterol. 2010 Jan;105(1):148-54. doi: 10.1038/ajg.2009.523. Epub 2009 Sep 15.

PMID:
19755964
34.

Phenotypic and genotypic analysis of enterotoxigenic Escherichia coli in samples obtained from Egyptian children presenting to referral hospitals.

Shaheen HI, Abdel Messih IA, Klena JD, Mansour A, El-Wakkeel Z, Wierzba TF, Sanders JW, Khalil SB, Rockabrand DM, Monteville MR, Rozmajzl PJ, Svennerholm AM, Frenck RW.

J Clin Microbiol. 2009 Jan;47(1):189-97. doi: 10.1128/JCM.01282-08. Epub 2008 Oct 29.

35.

Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.

Porter CK, El Mohammady H, Baqar S, Rockabrand DM, Putnam SD, Tribble DR, Riddle MS, Frenck RW, Rozmajzl P, Kilbane E, Fox A, Ruck R, Lim M, Johnston YJ, Murphy E, Sanders JW.

Clin Vaccine Immunol. 2008 Dec;15(12):1884-7. doi: 10.1128/CVI.00163-08. Epub 2008 Oct 8.

36.

Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.

Sanders JW, Frenck RW, Putnam SD, Riddle MS, Johnston JR, Ulukan S, Rockabrand DM, Monteville MR, Tribble DR.

Clin Infect Dis. 2007 Aug;45(3):294-301. doi: 10.1086/519264.

PMID:
18688944
37.

Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom.

Monteville MR, Riddle MS, Baht U, Putnam SD, Frenck RW, Brooks K, Moustafa M, Bland J, Sanders JW.

Am J Trop Med Hyg. 2006 Oct;75(4):762-7.

PMID:
17038708
38.

Cryptococcus neoformans var. gattii meningitis in Egypt: a case report.

Mansour A, Nakhla I, El Sherif M, Sultan YA, Frenck RW.

East Mediterr Health J. 2006 Jan-Mar;12(1-2):241-4. No abstract available.

39.

Sensitivity and specificity of various tests for the diagnosis of Helicobacter pylori in Egyptian children.

Frenck RW Jr, Fathy HM, Sherif M, Mohran Z, El Mohammedy H, Francis W, Rockabrand D, Mounir BI, Rozmajzl P, Frierson HF.

Pediatrics. 2006 Oct;118(4):e1195-202. Epub 2006 Sep 18.

PMID:
16982805
40.

Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA.

Am J Gastroenterol. 2006 Aug;101(8):1834-40. Epub 2006 Jun 30.

PMID:
16817843
41.

Enteric pathogens associated with diarrhea in children in Fayoum, Egypt.

El-Mohamady H, Abdel-Messih IA, Youssef FG, Said M, Farag H, Shaheen HI, Rockabrand DM, Luby SB, Hajjeh R, Sanders JW, Monteville MR, Klena JD, Frenck RW.

Diagn Microbiol Infect Dis. 2006 Sep;56(1):1-5. Epub 2006 May 3.

PMID:
16675181
42.

Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom.

Putnam SD, Sanders JW, Frenck RW, Monteville M, Riddle MS, Rockabrand DM, Sharp TW, Frankart C, Tribble DR.

J Travel Med. 2006 Mar-Apr;13(2):92-9.

43.

Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egypt.

Rockabrand DM, Shaheen HI, Khalil SB, Peruski LF Jr, Rozmajzl PJ, Savarino SJ, Monteville MR, Frenck RW, Svennerholm AM, Putnam SD, Sanders JW.

Diagn Microbiol Infect Dis. 2006 May;55(1):9-12. Epub 2006 Mar 20.

PMID:
16542813
44.

Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan).

Sanders JW, Putnam SD, Frankart C, Frenck RW, Monteville MR, Riddle MS, Rockabrand DM, Sharp TW, Tribble DR.

Am J Trop Med Hyg. 2005 Oct;73(4):713-9.

PMID:
16222015
45.

Knowledge, attitudes, and practices regarding epidemiology and management of travelers' diarrhea: a survey of front-line providers in Iraq and Afghanistan.

Riddle MS, Tribble DR, Jobanputra NK, Jones JJ, Putnam SD, Frenck RW, Sanders JW.

Mil Med. 2005 Jun;170(6):492-5.

PMID:
16001598
46.

Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001--Egypt.

Sanders JW, Putnam SD, Gould P, Kolisnyk J, Merced N, Barthel V, Rozmajzl PJ, Shaheen H, Fouad S, Frenck RW.

Diagn Microbiol Infect Dis. 2005 Jun;52(2):85-90.

PMID:
15964494
47.

Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.

Putnam SD, Sanders JW, Tribble DR, Rockabrand DR, Riddle MS, Rozmajzl PJ, Frenck RW.

Antimicrob Agents Chemother. 2005 Jun;49(6):2571-2.

48.

The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt.

Nakhla I, Frenck RW Jr, Teleb NA, El Oun S, Sultan Y, Mansour H, Mahoney F.

Vaccine. 2005 May 9;23(25):3288-93.

PMID:
15837234
49.

Relationship between intracranial granulomas and cerebrospinal fluid levels of gamma interferon and interleukin-10 in patients with tuberculous meningitis.

Mansour AM, Frenck RW Jr, Darville T, Nakhla IA, Wierzba TF, Sultan Y, Bassiouny MI, McCarthy K, Jacobs RF.

Clin Diagn Lab Immunol. 2005 Feb;12(2):363-5.

50.

Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.

Rao MR, Wierzba TF, Savarino SJ, Abu-Elyazeed R, El-Ghoreb N, Hall ER, Naficy A, Abdel-Messih I, Frenck RW Jr, Svennerholm AM, Clemens JD.

J Infect Dis. 2005 Feb 15;191(4):562-70. Epub 2005 Jan 14.

PMID:
15655780

Supplemental Content

Loading ...
Support Center